Stingl, Julia,
Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism Part II. Internal medicine / [electronic resource] : Internal medicine Julia Stingl (Kirchheiner). - London : Henry Stewart Talks, 2016. - 1 online resource (1 streaming video file (39 min.) : color, sound). - Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance. .
Animated audio-visual presentation with synchronized narration. Title from title frames. Updated version of a talk first published in 2007.
Contents: Genetic variability in pharmacokinetics -- Polymorphic drug-metabolizing enzymes (Cytochrome P450) -- Implementation of pharmacogenetics in drug therapy -- Risks and benefits of being a poor metabolizer -- Limitations of genetics-based dose adjustments -- Future clinical study directions in pharmacogenetics.
Access restricted to subscribers.
Mode of access: World Wide Web.
1087 Henry Stewart Talks
Cytochrome P-450.
Drugs--Metabolism.
Pharmacogenetics
Cytochrome P-450 Enzyme System.
Enzymes--pharmacokinetics.
Inactivation, Metabolic.
Pharmaceutical Preparations--metabolism.
Pharmacogenetics--methods.
Polymorphism, Genetic.
Risk Assessment.
Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism Part II. Internal medicine / [electronic resource] : Internal medicine Julia Stingl (Kirchheiner). - London : Henry Stewart Talks, 2016. - 1 online resource (1 streaming video file (39 min.) : color, sound). - Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance. .
Animated audio-visual presentation with synchronized narration. Title from title frames. Updated version of a talk first published in 2007.
Contents: Genetic variability in pharmacokinetics -- Polymorphic drug-metabolizing enzymes (Cytochrome P450) -- Implementation of pharmacogenetics in drug therapy -- Risks and benefits of being a poor metabolizer -- Limitations of genetics-based dose adjustments -- Future clinical study directions in pharmacogenetics.
Access restricted to subscribers.
Mode of access: World Wide Web.
1087 Henry Stewart Talks
Cytochrome P-450.
Drugs--Metabolism.
Pharmacogenetics
Cytochrome P-450 Enzyme System.
Enzymes--pharmacokinetics.
Inactivation, Metabolic.
Pharmaceutical Preparations--metabolism.
Pharmacogenetics--methods.
Polymorphism, Genetic.
Risk Assessment.